logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11007145 B1

PDFFull Text
Date of Patent:
May. 18, 2021

Filed:

Oct. 07, 2020

Gastroretentive dosage forms for sustained drug delivery

Applicant:

Kashiv Specialty Pharmaceuticals, Llc, Bridgewater, NJ (US);

Inventors:

Kanji Meghpara, Morris Plains, NJ (US);

Jaydeep Vaghashiya, Franklin Park, NJ (US);

Navnit H. Shah, Monmouth Junction, NJ (US);

Dipen Desai, Whippany, NJ (US);

Wantanee Phuapradit, Montville, NJ (US);

Harpreet Kaur Sandhu, West Orange, NJ (US);

Siva Ram Kiran Vaka, Piscataway, NJ (US);

Namdev B. Shelke, Somerville, NJ (US);

Ashish Chatterji, East Brunswick, NJ (US);

Assignee:

KASHIV SPECIALTY PHARMACEUTICALS, LLC, Bridgewater, NJ (US);

Attorneys:

Kashiv Specialty Pharmaceuticals

Vandana Awasthi

Primary Examiner:

Mina Haghighatian

Assistant Examiner:

Nathan W Schlientz

Int. Cl.
CPC ...
A61K 9/00 (2006.01); A61K 9/28 (2006.01); A61K 31/4412 (2006.01); A61K 31/403 (2006.01); A61K 31/421 (2006.01); A61K 31/195 (2006.01);
U.S. Cl.
CPC ...
A61K 9/0065 (2013.01); A61K 9/284 (2013.01); A61K 31/195 (2013.01); A61K 31/403 (2013.01); A61K 31/421 (2013.01); A61K 31/4412 (2013.01);
Abstract

The present disclosure is directed to floating gastroretentive dosage forms with prolonged gastric residence time. The disclosure also provides rapidly expanding sustained release or combined immediate release and sustained release formulations comprising drugs that require targeted release in the proximal gastrointestinal tract for maximum therapeutic benefit. The rapidly expanding floating gastroretentive dosage forms comprise a permeable elastic membrane providing desired characteristics for drug release and mechanical strength to maintain tablet integrity.

Find Patent Forward Citations

Meghpara, Kanji. (2021). Gastroretentive dosage forms for sustained drug delivery (U.S. Patent No. 11007145). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11007145

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…